Analysis of yeast prion aggregates with amyloid-staining compound in vivo

Cell Structure and Function

Volumn 28, Issue 3, 2003, Pages 187-193

  Kimura, Yoko ^a   Koitabashi, Sumiko ^a   Fujita, Takashi ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

Amyloid; Hsp104; Prion; Thioflavin S; Yeast

Indexed keywords

AMYLOID; PRION PROTEIN; THIOFLAVINE;

ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; IMMUNOFLUORESCENCE TEST; IN VIVO STUDY; NONHUMAN; PRION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN STRUCTURE; YEAST CELL;

EID: 0041825135     PISSN: 03867196     EISSN: None     Source Type: Journal    
DOI: 10.1247/csf.28.187     Document Type: Article

References (37)

1. Chernoff, Y.O., Derkach, I.L., and Inge-Vechtomov, S.G. 1993. Multicopy SUP35 gene induces de-novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae. Curr. Genet., 24: 268-270.
2. Chernoff, Y.O., Lindquist, S.L., Ono, B., Inge-Vechtomov, S.G., and Liebman, S.W. 1995. Role of the chaperone protein Hsp 104 in propagation of the yeast prion-like factor [psi+]. Science, 268: 880-884.
3. Chernoff, Y.O., Uptain, S.M., and Lindquist, S.L. 2002. Analysis of prion factors in yeast. Methods Enzymol., 351: 499-538.
4. Cox, B.S. 1965. PSI, a cytolasmic suppressor of super-suppressor in yeast. Heredity, 20: 505-521.
5. Derkatch, I.L., Bradley, M.E., Hong, J.Y., and Liebman, S.W. 2001. Prions affect the appearance of other prions: the story of [PIN(+)]. Cell, 106: 171-182.
6. Derkatch, I.L., Bradley, M.E., Zhou, P., Chernoff, Y.O., and Liebman, S.W. 1997. Genetic and environmental factors affecting the de novo appearance of the [PSI+] prion in Saccharomyces cerevisiae. Genetics, 147: 507-519.
7. Derkatch, I.L., Chernoff, Y.O., Kushnirov, V.V., Inge-Vechtomov, S.G., and Liebman, S.W. 1996. Genesis and variability of [PSI] prion factors in Saccharomyces cerevisiae. Genetics, 144: 1375-1386.
8. Dobson, C.M. 1999. Protein misfolding, evolution and disease. Trends Biochem. Sci., 24: 329-332.
9. Edskes, H.K., Gray, V.T., and Wickner, R.B. 1999. The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments. Proc. Natl. Acad. Sci. USA, 96: 1498-1503.
10. Glover, J.R., Kowal, A.S., Schirmer, E.C., Patino, M.M., Liu, J.J., and Lindquist, S. 1997. Self-seeded fibers formed by Sup35, the protein determinant of [PSI+], a heritable prion-like factor of S. cerevisiae. Cell., 89: 811-819.
11. Heiser, V., Scherzinger, E., Boeddrich, A., Nordhoff, E., Lutz, R., Schugardt, N., Lehrach, H., and Warker, E.E. 2000. Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy. Proc. Natl. Acad. Sci. USA, 97: 6739-6744.
12. Kikuchi, Y., Shimatake, H., and Kikuchi, A. 1988. A yeast gene required for the G1-to-S transition encodes a protein containing an A-kinase target site and GTPase domain. Embo J., 7: 1175-1182.
13. Kimura, Y., Koitabashi, S., Kakizuka, A., and Fujita, T. 2001. Initial process of polyglutamine aggregate formation in vivo. Genes Cells, 6: 887-897.
14. Kimura, Y., Koitabashi, S., Kakizuka, A., and Fujita, T. 2002. Circumvention of chaperone requirement for aggregate formation of a short polyglutamine tract by the co-expression of a long polyglutamine tract. J. Biol. Chem., 277: 37536-37541.
15. King, C.Y., Tittmann, P., Gross, H., Gebert, R., Aebi, M., and Wuthrich, K. 1997. Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. Proc. Natl. Acad. Sci. USA, 94: 6618-6622.
16. Koo, E.H., Lansbury, P.T., Jr., and Kelly, J.W. 1999. Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc. Natl. Acad. Sci. USA, 96: 9989-9990.
17. Lacroute, F. 1971. Non-Mendelian mutation allowing ureidosuccinic acid uptake in yeast. J. Bacteriol., 106: 519-522.
18. LeVine, H., 3rd. 1999. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol., 309: 274-284.
19. Maddelein, M.L., Dos Reis, S., Duvezin-Caubet, S., Coulary-Salin, B., and Saupe, S.J. 2002. Amyloid aggregates of the HET-s prion protein are infectious. Proc. Natl. Acad. Sci. USA, 99: 7402-7407.
20. Masison, D.C. and Wickner, R.B. 1995. Prion-inducing domain of yeast Ure2p and protease resistance of Ure2p in prion-containing cells. Science, 270: 93-95.
21. Moriyama, H., Edskes, H.K., and Wickner, R.B. 2000. [URE3] prion propagation in Saccharomyces cerevisiae: requirement for chaperone Hsp104 and curing by overexpressed chaperone Ydj1p. Mol. Cell. Biol., 20: 8916-8922.
22. Osherovich, L.Z. and Weissman, J.S. 2001. Multiple Gln/Asn-rich prion domains confer susceptibility to induction of the yeast [PSI(+)] prion. Cell, 106: 183-194.
23. Osherovich, L.Z. and Weissman, J.S. 2002. The utility of prions. Dev. Cell, 2: 143-151.
24. Patino, M.M., Liu, J.J., Glover, J.R., and Lindquist, S. 1996. Support for the prion hypothesis for inheritance of a phenotypic trait in yeast. Science, 273: 622-626.
25. Paushkin, S.V., Kushnirov, V.V., Smirnov, V.N., and Ter-Avanesyan, M.D. 1996. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. Embo. J., 15: 3127-3134.
26. Paushkin, S.V., Kushnirov, V.V., Smirnov, V.N., and Ter-Avanesyan, M.D. 1997. In vitro propagation of the prion-like state of yeast Sup35 protein. Science, 277: 381-383.
27. Prusiner, S.B. 1998. Prions. Proc. Natl. Acad. Sci. USA, 95: 13363-13383.
28. Schlumpberger, M., Wille, H., Baldwin, M.A., Butler, D.A., Herskowitz, I., and Prusiner, S.B. 2000. The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein. Protein Sci., 9: 440-451.
29. Serio, T.R. and Lindquist, S.S. 2001. [PSI+], SUP35, and chaperones. Adv. Protein Chem., 57: 335-366.
30. Sondheimer, N. and Lindquist, S. 2000. Rnq1: an epigenetic modifier of protein function in yeast. Mol. Cell, 5: 163-172.
31. Speransky, V.V., Taylor, K.L., Edskes, H.K., Wickner, R.B., and Steven, A.C. 2001. Prion filament networks in [URE3] cells of Saccharomyces cerevisiae. J. Cell Biol., 153: 1327-1336.
32. Taylor, K.L., Cheng, N., Williams, R.W., Steven, A.C., and Wickner, R.B. 1999. Prion domain initiation of amyloid formation in vitro from native Ure2p. Science, 283: 1339-1343.
33. Thual, C., Komar, A.A., Bousset, L., Fernandez-Bellot, E., Collin, C., and Melki, R. 1999. Structural characterization of Saccharomyces cerevisiae prion-like protein Ure2. J. Biol. Chem., 274: 13666-13674.
34. Weissmann, C. 1999. Molecular genetics of transmissible spongiform encephalopathies. J. Biol. Chem., 274: 3-6.
35. Westermark, G.T., Johnson, K.H., and Westermark, P. 1999. Staining methods for identification of amyloid in tissue. Methods Enzymol., 309: 3-25.
36. Wickner, R.B. 1994. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science, 264: 566-569.
37. Wickner, R.B., Edskes, H.K., Roberts, B.T., Pierce, M., and Baxa, U. 2002. Prions of yeast as epigenetic phenomena: high protein "copy number" inducing protein "silencing". Adv.